{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:57:15Z","timestamp":1790517435094,"version":"4.1.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,2]]},"abstract":"<jats:title>SUMMARY<\/jats:title>\n                  <jats:p>In gastroesophageal adenocarcinoma (GEA), recurrence following curative-intent resection represents one of the most clinically important outcomes. However, recurrence information is not consistently captured in structured fields within electronic health records (EHRs), and retrospective identification typically relies on labor-intensive manual chart review. We conducted a retrospective, single-center cohort study of patients with GEA who underwent R0 gastrectomy or esophagectomy from July 2020 to October 2024. A fully automated, rule-based natural language processing recurrence detection algorithm was developed using pathology and radiology reports extracted from the EHR. Definitive diagnostic statements in pathology reports were prioritized, while imaging-based recurrence required definitive diagnostic statements at \u22652 time points 14\u2013120\u00a0days apart. Algorithm performance was evaluated against manual chart review, which served as the reference standard for recurrence identification. Among 414 eligible patients, 126 (30.4%) experienced recurrence, with 3-year overall survival of 80.3% and recurrence-free survival of 59.3%. The most frequent sites of recurrence were distant lymph nodes, liver, and peritoneum. The algorithm demonstrated high discrimination, with a sensitivity of 90.5%, specificity of 95.1%, positive predictive value of 89.1%, negative predictive value of 95.8%, and accuracy of 93.7%. The median absolute difference in recurrence timing was 0\u00a0days, and site classification concordance was 91.2%. This proof-of-concept study demonstrates that postoperative recurrence in GEA can be identified with reasonable reliability using an automated, interpretable algorithm based solely on pathology and radiology reports. Automated recurrence detection may substantially reduce reliance on manual chart review and facilitate scalable real-world effectiveness research and long-term outcome evaluation.<\/jats:p>","DOI":"10.1093\/dote\/doag109","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T19:33:40Z","timestamp":1789673620000},"source":"Crossref","is-referenced-by-count":0,"title":["Automated detection of gastroesophageal adenocarcinoma recurrence from electronic health records"],"prefix":"10.1093","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5226-1347","authenticated-orcid":false,"given":"Jun","family":"Okui","sequence":"first","affiliation":[{"name":"Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather G","family":"Lyu","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura R","family":"Prakash","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny J","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariela A","family":"Blum-Murphy","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9946-0629","authenticated-orcid":false,"given":"Jaffer A","family":"Ajani","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne L","family":"Hofstetter","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center , Houston, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C","family":"Rice","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center , Houston, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul F","family":"Mansfield","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen G","family":"Swisher","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center , Houston, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3870-6968","authenticated-orcid":false,"given":"Matthew HG","family":"Katz","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9825-9234","authenticated-orcid":false,"given":"Naruhiko","family":"Ikoma","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,27]]},"reference":[{"key":"2026092709244660500_ref1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"2026092709244660500_ref2","doi-asserted-by":"publisher","first-page":"455","DOI":"10.5230\/jgc.2025.25.e33","article-title":"Investigating the synergistic effects of pembrolizumab and chemotherapy in gastric and gastroesophageal junction cancer","volume":"25","author":"Okui","year":"2025","journal-title":"J Gastric Cancer"},{"key":"2026092709244660500_ref3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10388-025-01113-y","article-title":"Investigating the synergistic effects of immunochemotherapy in esophageal squamous cell carcinoma","volume":"22","author":"Okui","year":"2025","journal-title":"Esophagus"},{"key":"2026092709244660500_ref4","doi-asserted-by":"publisher","first-page":"e1912869","DOI":"10.1001\/jamanetworkopen.2019.12869","article-title":"Feasibility of using real-world data to replicate clinical trial evidence","volume":"2","author":"Bartlett","year":"2019","journal-title":"JAMA Netw Open"},{"key":"2026092709244660500_ref5","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1001\/jamasurg.2026.0861","article-title":"Immunotherapy response in microsatellite instability\u2013high gastroesophageal adenocarcinoma","volume":"161","author":"Okui","year":"2026","journal-title":"JAMA Surg"},{"key":"2026092709244660500_ref6","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1093\/jnci\/djt270","article-title":"Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysis","volume":"105","author":"Oba","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"2026092709244660500_ref7","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s10120-024-01576-5","article-title":"Hazard rates of recurrence for gastric cancer after curative resection: implications for postoperative surveillance","volume":"28","author":"Kanematsu","year":"2025","journal-title":"Gastric Cancer"},{"key":"2026092709244660500_ref8","doi-asserted-by":"publisher","first-page":"e2300150","DOI":"10.1200\/CCI.23.00150","article-title":"Development of an automatic rule-based algorithm for the detection of ovarian cancer recurrence from electronic health records","volume":"8","author":"Lee","year":"2024","journal-title":"JCO Clin Cancer Inform"},{"key":"2026092709244660500_ref9","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1245\/s10434-014-3516-x","article-title":"Cancer recurrence: an important but missing variable in national cancer registries","volume":"21","author":"In","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"2026092709244660500_ref10","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1158\/1055-9965.EPI-17-1129","article-title":"Can we use survival data from cancer registries to learn about disease recurrence? The case of breast cancer","volume":"27","author":"Mariotto","year":"2018","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2026092709244660500_ref11","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/s41586-024-08167-5","article-title":"Automated real-world data integration improves cancer outcome prediction","volume":"636","author":"Jee","year":"2024","journal-title":"Nature"},{"key":"2026092709244660500_ref12","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1200\/CCI.20.00165","article-title":"Development and use of natural language processing for identification of distant cancer recurrence and sites of distant recurrence using unstructured electronic health record data","volume":"5","author":"Karimi","year":"2021","journal-title":"JCO Clin Cancer Inform"},{"key":"2026092709244660500_ref13","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1186\/s12885-021-08526-9","article-title":"Evaluation of algorithms using administrative health and structured electronic medical record data to determine breast and colorectal cancer recurrence in a Canadian province: using algorithms to determine breast and colorectal cancer recurrence","volume":"21","author":"Lambert","year":"2021","journal-title":"BMC Cancer"},{"key":"2026092709244660500_ref14","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.3390\/cancers15102741","article-title":"Machine learning algorithms to predict breast cancer recurrence using structured and unstructured sources from electronic health records","volume":"15","author":"Gonz\u00e1lez-Castro","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"Suppl 17","key":"2026092709244660500_ref15","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1186\/s12859-018-2466-x","article-title":"Using natural language processing and machine learning to identify breast cancer local recurrence","volume":"19","author":"Zeng","year":"2018","journal-title":"BMC Bioinformatics"},{"key":"2026092709244660500_ref16","doi-asserted-by":"publisher","first-page":"e297","DOI":"10.1371\/journal.pmed.0040297","article-title":"Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration","volume":"4","author":"Vandenbroucke","year":"2007","journal-title":"PLoS Med"},{"key":"2026092709244660500_ref17","doi-asserted-by":"publisher","first-page":"e012799","DOI":"10.1136\/bmjopen-2016-012799","article-title":"STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration","volume":"6","author":"Cohen","year":"2016","journal-title":"BMJ Open"},{"key":"2026092709244660500_ref18","first-page":"203","volume-title":"AJCC Cancer Staging Manual","author":"Washington","year":"2017","edition":"8"},{"key":"2026092709244660500_ref19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.21037\/acs.2017.03.14","article-title":"8th edition AJCC\/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice","volume":"6","author":"Rice","year":"2017","journal-title":"Ann Cardiothorac Surg"},{"key":"2026092709244660500_ref20","doi-asserted-by":"publisher","DOI":"10.1097\/sla.0000000000006919","article-title":"Recurrence-free survival as a surrogate endpoint for overall survival in resectable esophageal cancer: integrated analysis of individual patient data from phase III trials","author":"Okui","year":"2025","journal-title":"Ann Surg"},{"key":"2026092709244660500_ref21","doi-asserted-by":"publisher","first-page":"znae038","DOI":"10.1093\/bjs\/znae038","article-title":"Recurrence-free survival as a surrogate endpoint for overall survival after neoadjuvant chemotherapy and surgery for oesophageal squamous cell carcinoma","volume":"111","author":"Okui","year":"2024","journal-title":"Br J Surg"},{"key":"2026092709244660500_ref22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0140-6736(24)00745-1","article-title":"Doublet chemotherapy, triplet chemotherapy, or doublet chemotherapy combined with radiotherapy as neoadjuvant treatment for locally advanced oesophageal cancer (JCOG1109 NExT): a randomised, controlled, open-label, phase 3 trial","volume":"404","author":"Kato","year":"2024","journal-title":"Lancet"},{"key":"2026092709244660500_ref23","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1093\/jjco\/hyad150","article-title":"Protocol digest of a randomized controlled phase III study comparing surgery alone versus adjuvant nivolumab versus adjuvant S-1 for locally advanced oesophageal squamous cell carcinoma with no pathological complete response after neoadjuvant chemotherapy followed by curative esophagectomy: Japan clinical oncology group study JCOG2206 (SUNRISE trial)","volume":"54","author":"Kita","year":"2024","journal-title":"Jpn J Clin Oncol"},{"key":"2026092709244660500_ref24","doi-asserted-by":"publisher","first-page":"e2500215","DOI":"10.1200\/CCI-25-00215","article-title":"Ensuring reliability of curated electronic health record-derived data: the validation of accuracy for large language model\u2212\/machine learning-extracted information and data (VALID) framework","volume":"10","author":"Estevez","year":"2026","journal-title":"JCO Clin Cancer Inform"},{"key":"2026092709244660500_ref25","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.cmpb.2014.08.008","article-title":"Automated estimation of disease recurrence in head and neck cancer using routine healthcare data","volume":"117","author":"Ricketts","year":"2014","journal-title":"Comput Methods Programs Biomed"},{"key":"2026092709244660500_ref26","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1200\/CCI.20.00103","article-title":"Structured data capture for oncology","volume":"5","author":"Goel","year":"2021","journal-title":"JCO Clin Cancer Inform"},{"key":"2026092709244660500_ref27","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1200\/CCI.20.00174","article-title":"What oncologists want: identifying challenges and preferences on diagnosis data entry to reduce EHR-induced burden and improve clinical data quality","volume":"5","author":"Diaz-Garelli","year":"2021","journal-title":"JCO Clin Cancer Inform"},{"key":"2026092709244660500_ref28","doi-asserted-by":"publisher","first-page":"e0228545","DOI":"10.1371\/journal.pone.0228545","article-title":"Measuring follow-up time in routinely-collected health datasets: challenges and solutions","volume":"15","author":"Thayer","year":"2020","journal-title":"PLoS One"},{"key":"2026092709244660500_ref29","doi-asserted-by":"crossref","first-page":"djaf347","DOI":"10.1093\/jnci\/djaf347","article-title":"Conditional recurrence-free survival after curative esophagectomy: individual patient data analysis of 11 trials","volume":"118","author":"Okui","year":"2026","journal-title":"J Natl Cancer Inst"},{"key":"2026092709244660500_ref30","doi-asserted-by":"publisher","first-page":"5885","DOI":"10.1245\/s10434-023-13686-y","article-title":"Neoadjuvant chemotherapy or neoadjuvant chemoradiotherapy for patients with esophageal squamous cell carcinoma: real-world data comparison from a Japanese Nationwide study","volume":"30","author":"Okamura","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"2026092709244660500_ref31","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/pds.5444","article-title":"Real-world data: assessing electronic health records and medical claims data to support regulatory decision-making for drug and biological products","volume":"31","author":"Girman","year":"2022","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2026092709244660500_ref32","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.clinthera.2022.01.012","article-title":"Real-world evidence for regulatory decision-making: guidance from around the world","volume":"44","author":"Burns","year":"2022","journal-title":"Clin Ther"},{"key":"2026092709244660500_ref33","doi-asserted-by":"publisher","first-page":"znaf131","DOI":"10.1093\/bjs\/znaf131","article-title":"Evaluation of pathological complete response as a surrogate endpoint for overall survival in resectable oesophageal cancer: integrated analysis of individual patient data from phase III trials","volume":"112","author":"Okui","year":"2025","journal-title":"Br J Surg"},{"key":"2026092709244660500_ref34","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10388-022-00962-1","article-title":"A nationwide validation of the prognostic impact of pathological response and the distribution of recurrence patterns in responders after neoadjuvant chemotherapy for esophageal squamous cell carcinoma","volume":"20","author":"Matsuda","year":"2022","journal-title":"Esophagus"}],"container-title":["Diseases of the Esophagus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/dote\/article-pdf\/39\/5\/doag109\/71404828\/doag109.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/dote\/article-pdf\/39\/5\/doag109\/71404828\/doag109.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:24:53Z","timestamp":1790515493000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/dote\/article\/doi\/10.1093\/dote\/doag109\/8836768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9,2]]}},"URL":"https:\/\/doi.org\/10.1093\/dote\/doag109","relation":{},"ISSN":["1120-8694","1442-2050"],"issn-type":[{"value":"1120-8694","type":"print"},{"value":"1442-2050","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,9,2]]},"article-number":"doag109"}}